# The Optimization of Iron Bioavailability of Supplements Using Hepcidin Levels in Humans

> **NCT02050932** · NA · COMPLETED · sponsor: **Swiss Federal Institute of Technology** · enrollment: 32 (actual)

## Conditions studied

- Iron Deficiency

## Interventions

- **DIETARY_SUPPLEMENT:** 60 mg Fe as FeSO4 with stable isotopic labels

## Key facts

- **NCT ID:** NCT02050932
- **Lead sponsor:** Swiss Federal Institute of Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02050932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02050932, "The Optimization of Iron Bioavailability of Supplements Using Hepcidin Levels in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02050932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*